Literature DB >> 20198498

Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease.

Mohamed Ali Smach1, Bassem Charfeddine, Turkia Lammouchi, Leila Ben Othman, Afef Letaief, Souhir Nafati, Hedi Dridi, Soufien Bennamou, Khalifa Limem.   

Abstract

Alzheimer's disease (AD) is the leading cause of dementia. Several studies indicate a possible relationship between different genes and Alzheimer's disease. To further investigate, we have analyzed the association between the bleomycin hydrolase (BLMH) and apolipoprotein E (ApoE) polymorphisms in 93 AD patients and age- and sex-matched 113 controls from the Tunisian population. The frequency of ApoE epsilon 4 allele was found to differ significantly in AD patients compared to the control [29.5% vs. 8.8 (χ (2) = 26, df = 1, p < 0.001)] leading to an increased risk of AD in subjects with this allele (OR = 3.29, 95% CI = 1.7-6.5; p = 0.001]. This risk was found to decrease from OR = 8.4, CI = 3.3-23; p < 0.001 in subjects less than 75 years old to OR = 1.2, CI = 1.031-14; p = 0.0297 in subjects 75 years and older. No association was observed between carrying the BLMH-G genotype and AD in ε4 negative or positive subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198498     DOI: 10.1007/s10072-010-0234-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease.

Authors:  A Papassotiropoulos; M Bagli; F Jessen; C Frahnert; M L Rao; W Maier; R Heun
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

2.  Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Authors:  Asad Vaisi Raygani; Mahine Zahrai; Akbar Vaisi Raygani; Mahmood Doosti; Ebrahim Javadi; Mansour Rezaei; Tayebeh Pourmotabbed
Journal:  Neurosci Lett       Date:  2004-11-26       Impact factor: 3.046

3.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

4.  Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease.

Authors:  J Llorca; E Rodríguez-Rodríguez; T Dierssen-Sotos; M Delgado-Rodríguez; J Berciano; O Combarros
Journal:  Acta Neurol Scand       Date:  2007-09-14       Impact factor: 3.209

5.  APO E polymorphism in Spanish and Moroccan populations.

Authors:  N Valveny; E Esteban; M Kandil; P Moral
Journal:  Clin Genet       Date:  1997-05       Impact factor: 4.438

6.  Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease.

Authors:  P A O'Farrell; F Gonzalez; W Zheng; S A Johnston; L Joshua-Tor
Journal:  Structure       Date:  1999-06-15       Impact factor: 5.006

7.  [Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations].

Authors:  N Lahlali-Kacemi; Y Bamou; A Guedira; M Hassani; S Visvikis; G Siest; N Alami; O Kabbaj; M Lahrichi
Journal:  Ann Biol Clin (Paris)       Date:  2002 Jan-Feb       Impact factor: 0.459

8.  [Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases].

Authors:  V Nivet-Antoine; M-P Coulhon; C Le Denmat; B Hamon; X Dulcire; M Lefebvre; F Piette; P Davous; D Durand; D Duchassaing
Journal:  Ann Biol Clin (Paris)       Date:  2003 Jan-Feb       Impact factor: 0.459

9.  Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization.

Authors:  D Brömme; A B Rossi; S P Smeekens; D C Anderson; D G Payan
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

Review 10.  Interaction between genes and environment in neurodegenerative diseases.

Authors:  Alexis Elbaz; Carole Dufouil; Annick Alpérovitch
Journal:  C R Biol       Date:  2007-04-09       Impact factor: 1.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.